Congrats to our @UPMC_SurgRes Chief Residents, 7-8yrs of training done in a 💓! A pleasure to be part of your training. Ready to take on the world but always keep us close to your heart @aalthans@David_SilverMD@Yeahwa_Hong , Drew Sayce, Ahmed Hamed, Aly Morgan. @PittSurgery
Extended use of Impella 5.5 for >14d did not ⬆️ the rate of serious adverse events and provided hemodynamic support to a heterogenous group of pts presenting with cardiogenic shock with stable device performance
🔗: https://t.co/qGNTOZB6Us
@DavidKaczoro@GavHick@TheJHLT@ISHLT
Longer FWIT in DCD heart transplantation using DPP is associated with ⬇️ 1y post-transplant survival; careful recipient selection and risk stratification are essential to optimizing outcomes
🔗: https://t.co/Q9UXCzBX3r
@Yeahwa_Hong@AnderDorken@BrianEdWoolley@TransplantJrnl
Congratulations to Dr. @JuliePhillippi on her induction to the American Institute for Medical and Biomedical Engineering’s College of Fellows Class of 2026! Dr. Phillippi was recognized for her research investigating vasa vasorum and ECM in thoracic aortic disease @aimbe@HviUpmc
Congratulations to Dr. @Yeahwa_Hong who was recognized for authoring one of five most impactful papers of 2025 at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting! @ISHLT#ISHTL2026
Authors are presenting the 5️⃣ most impactful papers published in the #JHLT last year at #ISHLT2026. 🫀🫁The studies include: - A randomized trial of open lung protective ventilation vs conventional mechanical ventilation in deceased organ donors - Association of agonal phase duration with heart utilization + post-transplant outcomes in #DCD #HeartTx - ABO-incompatible heart transplants in children - A #CardiogenicShock Working Group registry analysis - A single-center study on high antiphospholipid antibody titers + outcomes of pulmonary endarterectomy
Moderate, controlled hypothermic preservation using SCTS significantly improves #HeartTx outcomes and 2-year survival. The first study of any advanced heart preservation method to show a major impact on survival rates. @ParagonixSherpa
🔗: https://t.co/jgID8KmiyB
A semi-empirical model provides a framework for understanding how circuit component selection impacts achievable blood flow and oxygen transfer in wearable artificial lung systems
🔗: https://t.co/0VM83E14IF
@Yeahwa_Hong@UkitaRei@PittSurgery@cmu_bme@asaiojournal
A UNOS registry analysis of #DCD#HTx with and without use of ex-vivo perfusion device showed that prolonged donor agonal period was associated with higher mortality & acute rejection in no-EHVP grafts, but #EVHP mitigated these risks. @AlexanderB21965
🔗: https://t.co/n9pYWb71GM
The TSRA app is now available on iOS. No more carrying six thick textbooks — everything's on my phone now. Search any topic in clinic and pull up the chapter instantly.
1/4 🧵 https://t.co/wQzi3duWIh
An exciting year for robotic cardiac surgery: a reflection on the field's growth in the context of training frameworks, evolving technology and increasingly standardized quality processes
🔗: https://t.co/H9UueJKyby
@AndreaAmabileMD@HviUpmc@annalsthorsurg
Studies using #rivaroxaban for permanent artificial lung support show that it has artificial surface anticoagulation efficacy similar to heparin and is feasible for oral administration in humans
🔗: https://t.co/difK6fKmJ6
@Yeahwa_Hong@cmu_bme@PittSurgery@TransplantJrnl#DOAC
Analysis of the impact of low diastolic blood pressure and resultant coronary hypoperfusion during the agonal phase on outcomes following #DCD#hearttx revealing that extensive coronary hypoperfusion during the agonal phase is associated with reduced transplant survival. @Yeahwa_Hong
🔗: https://t.co/9RNhIwslHE
Congrats to Dr. @Yeahwa_Hong, recipient of the SUS Resident Presentation Award for his presentation at the 2025 ASC! Dr. Hong presented his abstract at the Surgical Research Society 2026 Meeting at the Royal College of Surgeons of England on Jan 9.
@SocSARS@PittSurgery@UnivSurg